PRIMARY STUDY
Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series
Key Findings: The researchers concluded that co-administration of oral CBD in addition to basic psychiatric care was associated with reduction in symptoms of adult patients (91%) with PTSD.
Type of Study: Meta-analysis
Study Sample Size: 11
Study Result: Positive
Research Location(s): United States
Year of Pub: 2019
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Hemp derived
Chemotype: Chemotype III
Sub-Ratio: 0:1 (THC:CBD)
Dosage: CBD (22-28 mg once or twice daily as needed based on severity of symptoms. Liquid CBD contained about 1.5 mg of CBD per spray. Average total daily dose of CBD was 48.64 mg for the 8-week trial.)
Route of Administration: Oral (Ingestion), Sublingual/Oromucosal
Citation: Elms L, et al. Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series. J Altern Complement Med. 2019; 25:392-397. doi: 10.1089/acm.2018.0437
Authors: Elms L, Shannon S, Hughes S, Lewis N
